title: Expedited partner therapy for Chlamydia trachomatis at the community pharmacy.
abstract: OBJECTIVE
  Expedited partner treatment (EPT) for uncomplicated Chlamydia trachomatis at the pharmacy is an alternative approach to partner notification that has not yet been evaluated within the UK. The aim of this study was to evaluate EPT for partners using pharmacies in Lothian.
  
  
  METHODS
  A pilot study over 18 months.
  
  
  METHODS
  Selected healthcare settings and community pharmacies in Lothian, Scotland, UK.
  
  
  METHODS
  Sexual partners of index cases with uncomplicated C. trachomatis.
  
  
  METHODS
  Index cases with uncomplicated C. trachomatis were given a pharmacy voucher to pass onto sexual partners. Partners could redeem vouchers for free treatment (azithromycin) at one of 90 pharmacies in the area.
  
  
  METHODS
  The main outcome measure was the proportion of vouchers redeemed. Secondary outcomes included patient satisfaction, as determined at a telephone follow-up of a subgroup of female index cases from one study site, 1 month later.
  
  
  RESULTS
  In total 577 vouchers were issued to chlamydia-positive index patients of mean age 22.9 years (range 15-47 years). A total of 231 vouchers were redeemed (40%), at a median of 2 days after issue. Only 4% of partners attended a clinic for treatment. Most index patients surveyed reported that partners were satisfied with this method of treatment (48 out of 55; 87%).
  
  
  CONCLUSIONS
  Expedited partner treatment for uncomplicated chlamydia at a pharmacy is a popular choice, and increases options on where, when and how partners are treated.
authors.affiliation: Dean Terrace Centre, NHS Lothian, Edinburgh, UK.
authors.forename: S T
authors.initials: ST
authors.lastname: Cameron
authors.forename: A
authors.initials: A
authors.lastname: Glasier
authors.forename: A
authors.initials: A
authors.lastname: Muir
authors.forename: G
authors.initials: G
authors.lastname: Scott
authors.forename: A
authors.initials: A
authors.lastname: Johnstone
authors.forename: H
authors.initials: H
authors.lastname: Quarrell
authors.forename: C
authors.initials: C
authors.lastname: Oroz
authors.forename: M
authors.initials: M
authors.lastname: McIntyre
authors.forename: D
authors.initials: D
authors.lastname: Miranda
authors.forename: G
authors.initials: G
authors.lastname: Todd
mesh_terms: D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D017963:Azithromycin / Q000627:therapeutic use*; D002690:Chlamydia Infections / Q000188:drug therapy*; D002692:Chlamydia trachomatis; D011307:Drug Prescriptions / Q000706:statistics & numerical data; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010342:Patient Acceptance of Health Care / Q000706:statistics & numerical data; D010549:Personal Satisfaction; D010594:Pharmacies / Q000706:statistics & numerical data*; D010865:Pilot Projects; D012606:Scotland; D012747:Sexual Partners; D055815:Young Adult
chemical_list: D000900:Anti-Bacterial Agents; D017963:Azithromycin